BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16396244)

  • 1. Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis.
    Wozniak KL; Palmer G; Kutner R; Fidel PL
    Med Mycol; 2005 Nov; 43(7):589-601. PubMed ID: 16396244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local Th1/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-beta.
    Taylor BN; Saavedra M; Fidel PL
    Med Mycol; 2000 Dec; 38(6):419-31. PubMed ID: 11204879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida-specific antibodies during experimental vaginal candidiasis in mice.
    Wozniak KL; Wormley FL; Fidel PL
    Infect Immun; 2002 Oct; 70(10):5790-9. PubMed ID: 12228309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple experimental designs to evaluate the role of T-cell-mediated immunity against experimental vaginal Candida albicans infection.
    Wormley FL; Cutright J; Fidel PL
    Med Mycol; 2003 Oct; 41(5):401-9. PubMed ID: 14653516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to Candida.
    Fidel PL
    Oral Dis; 2002; 8 Suppl 2():69-75. PubMed ID: 12164664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1993 Oct; 61(10):4202-7. PubMed ID: 8406809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1994 Mar; 62(3):1032-8. PubMed ID: 8112837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathogenesis of recurrent vulvovaginal candidiasis.
    Fidel PL; Sobel JD
    Clin Microbiol Rev; 1996 Jul; 9(3):335-48. PubMed ID: 8809464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1995 Jul; 63(7):2403-8. PubMed ID: 7790050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1993 May; 61(5):1990-5. PubMed ID: 8097493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen.
    Fidel PL; Ginsburg KA; Cutright JL; Wolf NA; Leaman D; Dunlap K; Sobel JD
    J Infect Dis; 1997 Sep; 176(3):728-39. PubMed ID: 9291322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.
    Fidel PL; Lynch ME; Conaway DH; Tait L; Sobel JD
    Infect Immun; 1995 Feb; 63(2):547-53. PubMed ID: 7822020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local production of chemokines during experimental vaginal candidiasis.
    Saavedra M; Taylor B; Lukacs N; Fidel PL
    Infect Immun; 1999 Nov; 67(11):5820-6. PubMed ID: 10531235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New immunotherapeutic strategies to control vaginal candidiasis.
    Magliani W; Conti S; Cassone A; De Bernardis F; Polonelli L
    Trends Mol Med; 2002 Mar; 8(3):121-6. PubMed ID: 11879772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models.
    Fidel PL
    Int Rev Immunol; 2002; 21(6):515-48. PubMed ID: 12650240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis.
    Wormley FL; Chaiban J; Fidel PL
    Infect Immun; 2001 Aug; 69(8):5072-9. PubMed ID: 11447188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role for dendritic cells in immunoregulation during experimental vaginal candidiasis.
    LeBlanc DM; Barousse MM; Fidel PL
    Infect Immun; 2006 Jun; 74(6):3213-21. PubMed ID: 16714548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
    Zhang X; Li T; Chen X; Wang S; Liu Z
    BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia trachomatis infection does not enhance local cellular immunity against concurrent Candida vaginal infection.
    Kelly KA; Gray HL; Walker JC; Rank RG; Wormley FL; Fidel PL
    Infect Immun; 2001 May; 69(5):3451-4. PubMed ID: 11292774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.
    De Bernardis F; Lucciarini R; Boccanera M; Amantini C; Arancia S; Morrone S; Mosca M; Cassone A; Santoni G
    Infect Immun; 2006 Jul; 74(7):4282-94. PubMed ID: 16790803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.